Neumora Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NMRA and other ETFs, options, and stocks.

About NMRA

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. 

CEO
Paul L. Berns
CEOPaul L. Berns
Employees
110
Employees110
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2019
Founded2019
Employees
110
Employees110

NMRA Key Statistics

Market cap
345.87M
Market cap345.87M
Price-Earnings ratio
-1.41
Price-Earnings ratio-1.41
Dividend yield
Dividend yield
Average volume
1.69M
Average volume1.69M
High today
$2.15
High today$2.15
Low today
$2.05
Low today$2.05
Open price
$2.09
Open price$2.09
Volume
781.08K
Volume781.08K
52 Week high
$3.25
52 Week high$3.25
52 Week low
$0.611
52 Week low$0.611

Stock Snapshot

With a market cap of 345.87M, Neumora Therapeutics(NMRA) trades at $2.06. The stock has a price-to-earnings ratio of -1.41.

As of 2026-01-24, Neumora Therapeutics(NMRA) stock has fluctuated between $2.05 and $2.15. The current price stands at $2.06, placing the stock +0.5% above today's low and -4.2% off the high.

The Neumora Therapeutics(NMRA)'s current trading volume is 781.08K, compared to an average daily volume of 1.69M.

During the past year, Neumora Therapeutics(NMRA) stock moved between $0.61 at its lowest and $3.25 at its peak.

During the past year, Neumora Therapeutics(NMRA) stock moved between $0.61 at its lowest and $3.25 at its peak.

Analyst ratings

67%

of 9 ratings
Buy
66.7%
Hold
22.2%
Sell
11.1%

People also own

Based on the portfolios of people who own NMRA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.